NUVL
Nuvalent Inc
NasdaqGMUSDEQUITY
Healthcare
DELAYED
Neutral
+15/100
Last price
123.96
■ 0.00 (0.00%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
123.96
Day high
123.99
Day low
123.95
Volume
3.09M
Market cap
$9.81B
P/E (TTM)
—
52W range
71.13 – 123.99
Free account
3 more panels on NUVL open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
+24.93K
Net buying
Buy transactions
36
399.08K shares
Sell transactions
26
374.16K shares
Net transactions
+62
Buys less sells
Sell : buy shares
0.9 : 1
Mixed
Insider-held shares
2.20M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Jul 15, 26 | TURNER CHRISTOPHER DURANT Officer |
STOCK | 14.35K | $0 | Direct |
| Jul 15, 26 | BALCOM ALEXANDRA Chief Financial Officer |
STOCK | 14.35K | $0 | Direct |
| Jul 15, 26 | MILLER DEBORAH ANN Officer |
STOCK | 14.35K | $0 | Direct |
| Jul 15, 26 | PORTER JAMES RICHARD Chief Executive Officer |
STOCK | 40.02K | $0 | Direct |
| Jul 15, 26 | NOCI DARLENE Officer |
STOCK | 14.35K | $0 | Direct |
| Jul 15, 26 | PELISH HENRY E Officer |
STOCK | 14.35K | $0 | Direct |
| Jul 15, 26 | LANE BENJAMIN Chief Operating Officer |
STOCK | 7.12K | $0 | Direct |
| Jul 9, 26 | PELISH HENRY E Officer |
SELL | 2.11K | $261.36K | Direct |
| Jul 6, 26 | PORTER JAMES RICHARD Chief Executive Officer |
SELL | 30.00K | $3.71M | Direct |
| Jul 6, 26 | PORTER JAMES RICHARD Chief Executive Officer |
CONVERSION | 30.00K | $567.90K | Direct |
| Jul 1, 26 | BALCOM ALEXANDRA Chief Financial Officer |
SELL | 11.43K | $1.41M | Direct |
| Jul 1, 26 | NOCI DARLENE Officer |
SELL | 23.00K | $2.84M | Direct |
| Jul 1, 26 | BALCOM ALEXANDRA Chief Financial Officer |
CONVERSION | 11.43K | $151.55K | Direct |
| Jul 1, 26 | NOCI DARLENE Officer |
CONVERSION | 23.00K | $1.18M | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BOGLE GRANT C |
Director | 9.29K | Stock Award(Grant) |
FLYNN JAMES E |
Director and Beneficial Owner of more than 10% of a Class of Security | — | Stock Award(Grant) |
HACK ANDREW A. F. |
Director | — | Sale |
MEYERS MICHAEL L |
Director | 8.59K | Stock Award(Grant) |
OLIGER CHRISTY J |
Director | 7.42K | Stock Award(Grant) |
PROTOPAPAS ANNA |
Director | 8.59K | Stock Award(Grant) |
SHAIR MATTHEW |
Director | — | Sale |
SQUARER RON R |
Director | 6.28K | Stock Award(Grant) |
SRIVASTAVA SAPNA |
Director | 8.59K | Stock Award(Grant) |
WHEELER CAMERON PH.D. |
Director | 8.59K | Stock Award(Grant) |
Fundamentals
Market cap$9.81B
Enterprise value$8.51B
Revenue (TTM)—
Gross profit—
EBITDA—
Net income$-450.07M
EPS (TTM)$-6.06
Free cash flow$-180.43M
Total cash$1.29B
Total debt$0
Book value / share$14.89
Shares outstanding73.69M
Float49.11M
Short % of float6.17%
Dividend yield—
Beta (5Y)1.14
Valuation & profitability ratios
Trailing P/E—
Forward P/E-29.34
PEG ratio—
Price / sales—
Price / book8.33
EV / revenue—
EV / EBITDA—
Gross margin0.00%
Operating margin0.00%
Profit margin0.00%
Return on equity-41.19%
Return on assets-22.51%
Debt / equity—
Current ratio16.14
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Mar 2026 | -1.31 | -1.39 | -6.5% |
| Dec 2025 | -1.44 | -1.58 | -10.0% |
| Sep 2025 | -1.32 | -1.70 | -28.9% |
| Jun 2025 | -1.15 | -1.39 | -21.0% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | -1.38 | 9 | $0 | 0.0% |
| Next quarter | -1.40 | 9 | $1.40M | 0.0% |
| Current year | -5.50 | 10 | $10.74M | 0.0% |
| Next year | -4.02 | 10 | $181.03M | +1,586.1% |
Analyst targets & ownership
Mean target$124.00
High target$124.00
Low target$124.00
Implied upside0.03%
Analyst count9
ConsensusHOLD
Strong buy / Buy0 / 0
Hold9
Sell / Strong sell0 / 0
Held by insiders2.78%
Held by institutions113.30%
Institutions holding373
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
—
—
SMA 20
—
—
SMA 50
—
—
SMA 100
—
—
SMA 200
—
—
EMA 12
—
—
EMA 26
—
—
EMA 50
—
—
RSI (14)
—
—
MACD (12,26,9)
—
Hist —
ATR (14)
—
—
Realised vol 30D
—
Annualised
Bollinger upper
—
20, 2σ
Bollinger lower
—
20, 2σ
50 / 200 cross
—
—
Trend bias
—
—
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
—
—
Correlation to SPY
—
—
Realised vol 30D
—
Annualised
Market vol 1Y
—
SPY, annualised
Max drawdown 1Y
—
Peak to trough
Max drawdown 5Y
—
Peak to trough
ATR 14
—
Average true range
Beta (reported)
1.14
5Y monthly, from filing
Short interest
Shares short
2.91M
Prior 5.24M
Change vs prior
-44.5%
Shorts covering
% of float
6.17%
Normal
% of shares out
3.68%
Against total outstanding
Days to cover
0.6
Liquid
Float
49.11M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jun 24, 26 | Bernstein | DOWNGRADE | Outperform | Market Perform |
| Jun 10, 26 | Truist Securities | DOWNGRADE | Buy | Hold |
| Jun 10, 26 | TD Cowen | DOWNGRADE | Buy | Hold |
| Jun 10, 26 | Barclays | DOWNGRADE | Overweight | Equal-Weight |
| Jun 10, 26 | Wedbush | DOWNGRADE | Outperform | Neutral |
| Jun 10, 26 | UBS | DOWNGRADE | Buy | Neutral |
| Jun 10, 26 | Guggenheim | DOWNGRADE | Buy | Neutral |
| Jun 9, 26 | Wells Fargo | DOWNGRADE | Overweight | Equal-Weight |
| Jun 9, 26 | HC Wainwright & Co. | DOWNGRADE | Buy | Neutral |
| Jun 9, 26 | Cantor Fitzgerald | DOWNGRADE | Overweight | Neutral |
| Jun 9, 26 | Wedbush | DOWNGRADE | Outperform | Neutral |
| Jun 9, 26 | LifeSci Capital | DOWNGRADE | Outperform | Market Perform |
SEC filings
Notice of termination of registration of a class of securities under Section 12(g)
15-12G · 2026-07-27
Tender Offer/Acquisition Reports
SC 14D9/A · 2026-07-15
Tender Offer/Acquisition Reports
SC 14D9/A · 2026-07-07
Tender Offer/Acquisition Reports
SC TO-T/A · 2026-06-24
Corporate Changes & Voting Matters
8-K · 2026-06-18
Corporate Changes & Voting Matters
8-K · 2026-06-09
Corporate Changes & Voting Matters
8-K · 2026-05-07
Proxy Statements
DEF 14A · 2026-04-28
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.